SCHEMBL371141

SCHEMBL371141

Cc1cc(F)ccc1C(CC(=O)c1ccc(=O)n(C(=O)CC(c2ccc(Br)cc2)c2ccc(F)cc2C)c1)c1ccc(Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.37
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
KMT2A Q03164 3/20 0.35
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
CACNA1G O43497 1/20 0.33
KCNH2 Q12809 1/20 0.33
PPARG P37231 2/20 0.33
NQO1 P15559 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
BRD4 O60885 1/20 0.31
BRD2 P25440 1/20 0.31
BRD3 Q15059 1/20 0.31
BRDT Q58F21 1/20 0.31
MEN1 O00255 1/20 0.31
AKR1B10 O60218 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369509 0.88 KMT2A (0.45) GPBAR1MGAMGAASIMGAM2
SCHEMBL1390233 0.88 GPBAR1 (0.40) GPBAR1MGAMGAASIMGAM2
SCHEMBL362679 0.79 KEAP1 (0.43) GPBAR1KMT2AKEAP1NFE2L2PPARG
SCHEMBL370930 0.79 EPHX2 (0.45) MGAMGAASIMGAM2KMT2A
SCHEMBL369328 0.79 PPARG (0.38) GPBAR1MGAMGAASIMGAM2
SCHEMBL370467 0.77 KMT2A (0.41) GPBAR1MGAMGAASIMGAM2
SCHEMBL368765 0.76 ADORA3 (0.37) GPBAR1MGAMGAASIMGAM2
SCHEMBL368816 0.76 KMT2A (0.46) GPBAR1MGAMGAASIMGAM2
SCHEMBL370736 0.76 GPBAR1 (0.51) GPBAR1KMT2AKEAP1NFE2L2ALDH1A1
SCHEMBL369472 0.76 MGAM (0.35) GPBAR1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885MGAM 2443/4885GAA 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.